A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.
Haidinger
Michael
M
Clinical Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Austria.
Werzowa
Johannes
J
Voigt
Hans-Christian
HC
Pleiner
Johannes
J
Stemer
Gunar
G
Hecking
Manfred
M
Döller
Dominik
D
Hörl
Walter H
WH
Weichhart
Thomas
T
Säemann
Marcus D
MD